Entering text into the input field will update the search result below

Portola Pharmaceuticals beats by $0.19, beats on revenue

Nov. 09, 2015 4:30 PM ETPortola Pharmaceuticals, Inc. (PTLA) StockBy: Gaurav Batavia, SA News Editor1 Comment
  • Portola Pharmaceuticals (NASDAQ:PTLA): Q3 EPS of -$1.05 beats by $0.19.
  • Revenue of $2.91M (+19.8% Y/Y) beats by $0.46M.
  • Press Release

Recommended For You

Related Stocks

SymbolLast Price% Chg
PTLA--
Portola Pharmaceuticals, Inc.